Journal ArticleDOI
Pink Ribbons, Inc
About:
This article is published in Lancet Oncology.The article was published on 2012-04-01. It has received 66 citations till now.read more
Citations
More filters
Journal ArticleDOI
The Nature of Slacktivism: How the Social Observability of an Initial Act of Token Support Affects Subsequent Prosocial Action
TL;DR: The authors proposed a conceptual framework elucidating two primary motivations that underlie subsequent helping behavior: a desire to present a positive image to others and the desire to be consistent with one's own values.
Journal ArticleDOI
The ethical, legal and social implications of using artificial intelligence systems in breast cancer care
Stacy M Carter,Wendy A Rogers,Khin Than Win,Helen Frazer,Bernadette Richards,Nehmat Houssami +5 more
TL;DR: The ethical, legal and social implications of developments in artificial intelligence in breast cancer care, including applications including screening and diagnosis, risk calculation, prognostication and clinical decision-support, management planning, and precision medicine are reviewed.
Journal ArticleDOI
Can supporting a cause decrease donations and happiness? The cause marketing paradox
TL;DR: In two laboratory and one pilot field study, the authors demonstrate that cause marketing, whereby firms link products with a cause and share proceeds with it, reduces charitable giving by consumers, even when it is costless to the consumer to buy on CM (versus not); further, instead of increasing total contribution to the cause, it can decrease it.
Journal ArticleDOI
‘The Medical’ and ‘Health’ in a Critical Medical Humanities
TL;DR: The conceptual underpinnings for a distinction between ‘the medical’ and ‘health’ are revisited by looking at the history of an analogous debate between “medical geography” and “the geographies of health” that has, over the last few years, witnessed a re-blurring of the distinction.
Journal ArticleDOI
'Just give me the best quality of life questionnaire': the Karnofsky scale and the history of quality of life measurements in cancer trials.
TL;DR: It is argued that the Karnofsky scale provided a quick and simple, approximate assessment of the ‘soft’ effects of treatment by physicians, overlapping but not identical with quality of life.